Leerink Partnrs Analysts Boost Earnings Estimates for THC

Key Points

• Leerink Partners has raised its earnings estimate for Tenet Healthcare to $3.17 per share for Q3 2026, an increase from their previous estimate of $2.91.
• Morgan Stanley recently increased Tenet Healthcare's target price from $175.00 to $210.00, indicating a strong bullish sentiment for the stock.
• The stock has a current consensus rating of "Moderate Buy" among analysts, with an average price target of $187.12.

Tenet Healthcare Corporation (NYSE:THC - Free Report) - Equities research analysts at Leerink Partnrs raised their Q3 2026 earnings estimates for Tenet Healthcare in a research report issued on Wednesday, July 23rd. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $3.17 per share for the quarter, up from their prior estimate of $2.91. The consensus estimate for Tenet Healthcare's current full-year earnings is $12.24 per share.

Other equities analysts have also recently issued research reports about the stock. Morgan Stanley raised their target price on shares of Tenet Healthcare from $175.00 to $210.00 and gave the stock an "overweight" rating in a report on Monday, June 9th. Baird R W downgraded Tenet Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Wells Fargo & Company upgraded Tenet Healthcare from an "equal weight" rating to an "overweight" rating and upped their price objective for the stock from $150.00 to $195.00 in a research note on Thursday, May 29th. Wall Street Zen downgraded Tenet Healthcare from a "buy" rating to a "hold" rating in a research note on Friday, July 18th. Finally, Guggenheim upped their price objective on Tenet Healthcare from $180.00 to $188.00 and gave the stock a "buy" rating in a research note on Wednesday. Four analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $187.12.

Tenet Healthcare Stock Performance

Shares of THC opened at $147.99 on Friday. The business's fifty day moving average price is $168.42 and its 200 day moving average price is $145.02. Tenet Healthcare has a 12-month low of $109.82 and a 12-month high of $185.25. The stock has a market capitalization of $13.75 billion, a PE ratio of 9.47, a price-to-earnings-growth ratio of 0.81 and a beta of 1.64. The company has a debt-to-equity ratio of 2.39, a current ratio of 1.71 and a quick ratio of 1.70.

Tenet Healthcare (NYSE:THC - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The company reported $4.02 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.84 by $1.18. Tenet Healthcare had a net margin of 7.17% and a return on equity of 24.69%. The business had revenue of $5.27 billion during the quarter, compared to analyst estimates of $5.16 billion. During the same quarter in the previous year, the firm earned $2.31 earnings per share. The business's revenue was up 3.2% compared to the same quarter last year.

Insider Transactions at Tenet Healthcare

In related news, EVP Paola M. Arbour sold 7,738 shares of the firm's stock in a transaction that occurred on Thursday, June 5th. The shares were sold at an average price of $173.00, for a total transaction of $1,338,674.00. Following the completion of the sale, the executive vice president directly owned 20,110 shares in the company, valued at approximately $3,479,030. This trade represents a 27.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Richard W. Fisher sold 3,077 shares of the stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $165.72, for a total transaction of $509,920.44. Following the completion of the sale, the director owned 12,128 shares of the company's stock, valued at approximately $2,009,852.16. The trade was a 20.24% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 54,121 shares of company stock worth $8,846,305. 0.81% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Tenet Healthcare

A number of large investors have recently bought and sold shares of THC. US Bancorp DE raised its holdings in Tenet Healthcare by 0.8% in the 1st quarter. US Bancorp DE now owns 8,620 shares of the company's stock worth $1,159,000 after acquiring an additional 68 shares during the period. Farther Finance Advisors LLC increased its holdings in Tenet Healthcare by 2.8% in the 2nd quarter. Farther Finance Advisors LLC now owns 2,615 shares of the company's stock valued at $460,000 after buying an additional 70 shares during the period. Lindbrook Capital LLC increased its holdings in Tenet Healthcare by 5.3% in the 1st quarter. Lindbrook Capital LLC now owns 1,427 shares of the company's stock valued at $192,000 after buying an additional 72 shares during the period. Signaturefd LLC increased its holdings in Tenet Healthcare by 11.2% in the 2nd quarter. Signaturefd LLC now owns 732 shares of the company's stock valued at $129,000 after buying an additional 74 shares during the period. Finally, Vista Investment Partners LLC lifted its holdings in shares of Tenet Healthcare by 0.3% during the second quarter. Vista Investment Partners LLC now owns 25,257 shares of the company's stock valued at $4,445,000 after acquiring an additional 76 shares during the period. 95.44% of the stock is currently owned by institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.